| 15d-PGJ2 | 15-deoxy-Δ12,14-prostaglandin J2 |
| Ach | Acetylcholine |
| AchE | Acetylcholinesterase |
| AP | Anterior/posterior |
| ASD | Autism spectrum disorder |
| BCT | Beam crossing task |
| BNDF | Brain-derived neurotrophic factor |
| BTBR | BTBR T+tf/J |
| CREB | Cyclic AMP response element binding protein |
| CSF | Cerebrospinal fluid |
| DV | Dorsal/ventral |
| ELT | Escape latency time |
| FST | Forced swim test |
| FXR | FarnesoidX receptor |
| GST | Guggulsterone |
| IAEC | Institutional Animal Ethics Committee |
| ICV-PPA | Intracerebroventricular-propionic acid |
| IL-1β | Interleukin 1 beta |
| JAK | Janus kinase |
| LDH | Lactate dehydrogenase |
| MBP | Myelin basic protein |
| MDA | Malondialdehyde |
| ML | Medial/lateral |
| MWM | Morris water maze |
| NO | Nitric oxide |
| PPAR | Peroxisome proliferator-activated receptor |
| SHP-1 | Srchomology 2 domain-containing protein tyrosine |
| SOD | Superoxide dismutase |
| STAT3 | Signal transducer and activator of transcription 3 |
| TNF-α | Tumornecrotic factor-alpha |
| TSTQ | Time spent in target quadrant |